Rare diseases
Investigational molecules
Locations
Back to Italy885 clinical trials in Bologna, Italy across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyStudy of Mezagitamab in Adults with Primary IgA Nephropathy (Berger's Disease) to Reduce Protein in Urine
ItalyStudy of Dapagliflozin for Reducing Cardiovascular Events in Adults with High Blood Pressure
ItalyComparing piperacillin-tazobactam and meropenem for treating bloodstream infections caused by cephalosporin-resistant bacteria in adult patients
ItalyStudy of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases
ItalyStudy of Rilvegostomig with Bevacizumab and Tremelimumab as First-line Treatment for Patients with Advanced Liver Cancer
ItalyStudy of carboplatin, paclitaxel, and tislelizumab treatment in patients with resectable locally advanced oral cavity squamous cell carcinoma
ItalyStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
ItalyEvaluating sacituzumab tirumotecan alone or with pembrolizumab compared to standard treatment in untreated patients with metastatic triple-negative breast cancer with low PD-L1 expression
ItalyStudy of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies
ItalyStudy of Bleximenib, Venetoclax, and Azacitidine Treatment for Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
ItalyStudy Comparing Golcadomide and Rituximab with Other Treatments for Patients with Relapsed or Refractory Follicular Lymphoma
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Immune Thrombocytopenia and various forms of blood cancers including Acute Myeloid Leukemia and Multiple Myeloma. These trials aim to evaluate novel therapeutic approaches and combination treatments.
Studies include evaluation of new compounds and their safety profiles in treating various blood-related conditions.
Comprehensive studies on inflammatory bowel conditions, focusing on Crohn's Disease and Ulcerative Colitis. Research aims to develop more effective treatments for patients with moderate to severe disease activity.
Trials evaluate both induction therapy and long-term treatment options for gastrointestinal conditions.
Investigation of treatments for sleep disorders including Narcolepsy and Idiopathic Hypersomnia, along with research into Chronic Inflammatory Demyelinating Polyneuropathy.
Focus on developing safer and more effective therapies for various neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
